Indication
Citrobacter pneumonia
Citrobacter pneumonia is an uncommon lower respiratory tract infection caused by Gram-negative bacilli of the genus *Citrobacter*, most frequently *Citrobacter freundii* or *Citrobacter koseri*. Read more about Citrobacter pneumonia
34 drugs 21 manufacturers
Drugs that treat it
Common Citrobacter pneumonia therapies.
TAZICEF (ceftazidime)
GENTAMICIN SULFATE (gentamicin sulfate/PF)
FORTAZ (ceftazidime)
GENTAMICIN SULFATE
GENTAMICIN SULFATE
GENTAMICIN SULFATE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonCitrobacter pneumonia is an uncommon lower respiratory tract infection caused by Gram-negative bacilli of the genus *Citrobacter*, most frequently *Citrobacter freundii* or *Citrobacter koseri*.
It primarily occurs as an opportunistic, nosocomial infection in hospitalized patients, mechanically ventilated individuals, neonates, elderly populations, and immunocompromised hosts with significant comorbidities.
Pathophysiologically, colonization and subsequent invasion of the pulmonary parenchyma trigger alveolar inflammation and tissue damage, often presenting with fever, dyspnea, hypoxemia, purulent sputum production, and radiologic evidence of pulmonary infiltrates or consolidation.
Because *Citrobacter* species frequently possess chromosomal AmpC beta-lactamases or other multi-drug resistance mechanisms, the infection can follow an aggressive clinical course and is often complicated by lung cavitation, empyema, bacteremia, and septic shock.
- nih.gov
Citrobacter pneumonia is an uncommon lower respiratory tract infection caused by Gram-negative bacilli of the genus *Citrobacter*, most frequently *Citrobacter freundii* or *Citrobacter koseri* It primarily occurs as an opportunistic, nosocomial infection in hospitalized patients, mechanically ventilated individuals, neonates, elderly populations, and immunocompromised hosts with significant comorbidities
- nih.gov
Citrobacter pneumonia is an uncommon lower respiratory tract infection caused by Gram-negative bacilli of the genus *Citrobacter*, most frequently *Citrobacter freundii* or *Citrobacter koseri* It primarily occurs as an opportunistic, nosocomial infection in hospitalized patients, mechanically ventilated individuals, neonates, elderly populations, and immunocompromised hosts with significant comorbidities Pathophysiologically, colonization and subsequent invasion of the pulmonary parenchyma trig...
- nih.gov
It primarily occurs as an opportunistic, nosocomial infection in hospitalized patients, mechanically ventilated individuals, neonates, elderly populations, and immunocompromised hosts with significant comorbidities
- nih.gov
Pathophysiologically, colonization and subsequent invasion of the pulmonary parenchyma trigger alveolar inflammation and tissue damage, often presenting with fever, dyspnea, hypoxemia, purulent sputum production, and radiologic evidence of pulmonary infiltrates or consolidation
- nih.gov
Because *Citrobacter* species frequently possess chromosomal AmpC beta-lactamases or other multi-drug resistance mechanisms, the infection can follow an aggressive clinical course and is often complicated by lung cavitation, empyema, bacteremia, and septic shock
- nih.gov
Because *Citrobacter* species frequently possess chromosomal AmpC beta-lactamases or other multi-drug resistance mechanisms, the infection can follow an aggressive clinical course and is often complicated by lung cavitation, empyema, bacteremia, and septic shock
Personalize your experience
Follow Citrobacter pneumonia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.